{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:23:28Z","timestamp":1794936208237,"version":"4.9.1"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"publisher","award":["R-932093"],"award-info":[{"award-number":["R-932093"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"publisher","award":["R-840401"],"award-info":[{"award-number":["R-840401"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"name":"King Gustav Vth 80-year foundation","award":["FAI-2019\u20130577"],"award-info":[{"award-number":["FAI-2019\u20130577"]}]},{"name":"King Gustav Vth 80-year foundation","award":["FAI-2019\u20130628"],"award-info":[{"award-number":["FAI-2019\u20130628"]}]},{"DOI":"10.13039\/501100007366","name":"Agnes and Mac Rudberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007366","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Signe and Reinhold Sund\u2019s Foundation for Rheumatological Research"},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ingegerd Johansson Donation","award":["SLS-713911"],"award-info":[{"award-number":["SLS-713911"]}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2019\u201301632"],"award-info":[{"award-number":["2019\u201301632"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2018\u201302535"],"award-info":[{"award-number":["2018\u201302535"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009230","name":"Uppsala County Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholm County Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Swedish Heart-Lung Foundation","doi-asserted-by":"publisher","award":["20170257"],"award-info":[{"award-number":["20170257"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Swedish Heart-Lung Foundation","doi-asserted-by":"publisher","award":["20190510"],"award-info":[{"award-number":["20190510"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>In SLE, anti-dsDNA can co-occur with autoantibodies against other chromatin components, like histones and nucleosomes. These antibodies induce type-1 interferon production, a hallmark of SLE. We measured ANA sub-specificities and investigated their associations to inflammatory biomarkers including interferon-regulated chemokines.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We included 93 Sudanese and 480 Swedish SLE patients and matched controls (N\u2009=\u2009104\u2009+\u2009192). Autoantibodies targeting ANA sub-specificities: dsDNA, Sm, Sm\/U1RNPcomplex, U1RNP, SSA\/Ro52, SSA\/Ro60, SSB\/La, ribosomal P, PCNA and histones were quantified in all subjects, anti-nucleosome only in the Swedish patients, with a bead-based multiplex immunoassay. Levels of 72 plasma biomarkers were determined with the Proximity Extension Assay technique or ELISA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among Sudanese patients, the investigated antibodies were significantly associated with 9\/72 biomarkers. Anti-histone antibodies showed the strongest positive correlations with MCP-3 and S100A12 as well as with interferon I-inducible factors MCP-1 and CXCL10. Anti-dsDNA antibodies were associated with CXCL10 and S100A12, but in multivariate analyses, unlike anti-histone, associations lost significance.<\/jats:p>\n                  <jats:p>Among Swedish patients, MCP-1, CXCL10, and SA100A12 also demonstrated stronger associations to anti-histone and anti-nucleosome antibodies, compared with anti-dsDNA and other ANA sub-specificities. In multiple regression models, anti-histone\/nucleosome retained the strongest associations. When excluding anti-histone or anti-nucleosome positive patients, the associations between MCP-1\/CXCL10 and anti-dsDNA were lost. In contrast, when excluding anti-dsDNA positive patients, associations with anti-histone and anti-nucleosome remained significant.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In two cohorts of different ethnical origins, autoantibodies targeting chromatin correlate stronger with IFN-induced inflammatory biomarkers than anti-dsDNA or other ANA sub-specificities. Our results suggest that anti-histone\/nucleosome autoantibodies may be the main drivers of type-1 interferon activity in SLE.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae134","type":"journal-article","created":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T21:58:38Z","timestamp":1710021518000},"page":"1170-1178","source":"Crossref","is-referenced-by-count":8,"title":["Anti-histone and anti-nucleosome rather than anti-dsDNA antibodies associate with IFN-induced biomarkers in Sudanese and Swedish SLE patients"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2515-7066","authenticated-orcid":false,"given":"Sahwa","family":"Elbagir","sequence":"first","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University , Uppsala,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NasrEldeen A","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Faculty of Medical Laboratory Sciences, Al Neelain University , Khartoum,","place":["Sudan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilija","family":"Oke","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institute, Karolinska University Hospital , Stockholm,","place":["Sweden"]},{"name":"Centre for Rheumatology, Academic Specialist Centre , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Larsson","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Section of Clinical Chemistry, Uppsala University , Uppsala,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9752-7479","authenticated-orcid":false,"given":"Jan","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Experimental Medical Science, Lund University , Lund,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Elshafie","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University , Uppsala,","place":["Sweden"]},{"name":"Department of Clinical Immunology and Transfusion Medicine, Link\u00f6ping University Hospital , Link\u00f6ping,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnour M","family":"Elagib","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Military Hospital , Omdurman,","place":["Sudan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa A M","family":"Nur","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Alribat University Hospital , Khartoum,","place":["Sudan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Gunnarsson","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institute, Karolinska University Hospital , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3396-3244","authenticated-orcid":false,"given":"Elisabet","family":"Svenungsson","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institute, Karolinska University Hospital , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1186-3226","authenticated-orcid":false,"given":"Johan","family":"R\u00f6nnelid","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University , Uppsala,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,9]]},"reference":[{"key":"2025030500184472300_keae134-B1","doi-asserted-by":"crossref","first-page":"368274","DOI":"10.1155\/2014\/368274","article-title":"The spectrum of anti-chromatin\/nucleosome autoantibodies: independent and interdependent biomarkers of disease","volume":"2014","author":"Mehra","year":"2014","journal-title":"J Immunol Res"},{"key":"2025030500184472300_keae134-B2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"2025030500184472300_keae134-B3","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1172\/JCI116378","article-title":"Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen","volume":"91","author":"Burlingame","year":"1993","journal-title":"J Clin Invest"},{"key":"2025030500184472300_keae134-B4","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.4049\/jimmunol.168.5.2530","article-title":"Naturally processed chromatin peptides reveal a major autoepitope that primes pathogenic T and B cells of lupus","volume":"168","author":"Kaliyaperumal","year":"2002","journal-title":"J Immunol"},{"key":"2025030500184472300_keae134-B5","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1002\/art.1780401210","article-title":"Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production","volume":"40","author":"Voll","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2025030500184472300_keae134-B6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI23025","article-title":"Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9","volume":"115","author":"Means","year":"2005","journal-title":"J Clin Invest"},{"key":"2025030500184472300_keae134-B7","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1002\/art.24686","article-title":"Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells","volume":"60","author":"Eloranta","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2025030500184472300_keae134-B8","doi-asserted-by":"crossref","first-page":"e000270","DOI":"10.1136\/lupus-2018-000270","article-title":"Interferon pathway in SLE: one key to unlocking the mystery of the disease","volume":"6","author":"R\u00f6nnblom","year":"2019","journal-title":"Lupus Sci Med"},{"key":"2025030500184472300_keae134-B9","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1182\/blood-2018-11-844530","article-title":"Neutrophils and NETs in modulating acute and chronic inflammation","volume":"133","author":"Castanheira","year":"2019","journal-title":"Blood"},{"key":"2025030500184472300_keae134-B10","doi-asserted-by":"crossref","first-page":"102374","DOI":"10.1016\/j.jaut.2019.102374","article-title":"Inflammatory markers in systemic lupus erythematosus","volume":"110","author":"Aringer","year":"2020","journal-title":"J Autoimmun"},{"key":"2025030500184472300_keae134-B11","doi-asserted-by":"crossref","first-page":"688753","DOI":"10.3389\/fimmu.2021.688753","article-title":"Comparison of surrogate markers of the type I interferon response and their ability to mirror disease activity in systemic lupus erythematosus","volume":"12","author":"Enocsson","year":"2021","journal-title":"Front Immunol"},{"key":"2025030500184472300_keae134-B12","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002876","article-title":"Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider","volume":"9","author":"Burska","year":"2023","journal-title":"RMD Open"},{"key":"2025030500184472300_keae134-B13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/sj.gene.6364408","article-title":"High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus","volume":"8","author":"Niewold","year":"2007","journal-title":"Genes Immun"},{"key":"2025030500184472300_keae134-B14","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/art.21890","article-title":"Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies","volume":"54","author":"Hua","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2025030500184472300_keae134-B15","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1371\/journal.pmed.0030491","article-title":"Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus","volume":"3","author":"Bauer","year":"2006","journal-title":"PLoS Med"},{"key":"2025030500184472300_keae134-B16","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1002\/art.24803","article-title":"Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study","volume":"60","author":"Bauer","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2025030500184472300_keae134-B17","doi-asserted-by":"crossref","first-page":"21126","DOI":"10.1038\/s41598-020-78213-5","article-title":"Accumulation of antinuclear associated antibodies in circulating immune complexes is more prominent in SLE patients from Sudan than Sweden","volume":"10","author":"Elbagir","year":"2020","journal-title":"Sci Rep"},{"key":"2025030500184472300_keae134-B18","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/rheumatology\/kez323","article-title":"Sudanese and Swedish patients with systemic lupus erythematosus: immunological and clinical comparisons","volume":"59","author":"Elbagir","year":"2020","journal-title":"Rheumatology (Oxford, England)"},{"key":"2025030500184472300_keae134-B19","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"2025030500184472300_keae134-B20","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2025030500184472300_keae134-B21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/cei.12651","article-title":"Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus","volume":"181","author":"Svenungsson","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"2025030500184472300_keae134-B22","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/art.30187","article-title":"Network analysis of associations between serum interferon-\u03b1 activity, autoantibodies, and clinical features in systemic lupus erythematosus","volume":"63","author":"Weckerle","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2025030500184472300_keae134-B23","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025030500184472300_keae134-B24","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease","volume":"52","author":"Kirou","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2025030500184472300_keae134-B25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13075-019-1878-y","article-title":"High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus","volume":"21","author":"Oke","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2025030500184472300_keae134-B26","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/annrheumdis-2021-221662","article-title":"Anti-RNP antibodies are associated with the interferon gene signature but not decreased complement levels in SLE","volume":"81","author":"Hubbard","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025030500184472300_keae134-B27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4081\/reumatismo.2020.1308","article-title":"Measurement of serum interferon alpha in Egyptian patients with systemic lupus erythematosus and evaluation of its effect on disease activity: a case-control study","volume":"72","author":"Fayed","year":"2020","journal-title":"Reumatismo"},{"key":"2025030500184472300_keae134-B28","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1136\/annrheumdis-2015-208140","article-title":"Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification","volume":"75","author":"Munroe","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2025030500184472300_keae134-B29","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/1529-0131(200010)43:10<2307::AID-ANR19>3.0.CO;2-J","article-title":"Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus","volume":"43","author":"Bruns","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2025030500184472300_keae134-B30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00002281-200009000-00003","article-title":"The role of nucleosomes in lupus","volume":"12","author":"Amoura","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"2025030500184472300_keae134-B31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/acr2.11343","article-title":"Four systemic lupus erythematosus subgroups, defined by autoantibodies status, differ regarding HLA-DRB1 genotype associations and immunological and clinical manifestations","volume":"4","author":"Diaz-Gallo","year":"2021","journal-title":"ACR Open Rheumatol"},{"key":"2025030500184472300_keae134-B32","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00109-016-1421-4","article-title":"Cause and consequences of the activated type I interferon system in SLE","volume":"94","author":"Eloranta","year":"2016","journal-title":"J Mol Med (Berl)"},{"key":"2025030500184472300_keae134-B33","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1182\/blood-2005-07-2650","article-title":"U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7","volume":"107","author":"Savarese","year":"2006","journal-title":"Blood"},{"key":"2025030500184472300_keae134-B34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaut.2016.12.005","article-title":"Pathways of impending disease flare in African-American systemic lupus erythematosus patients","volume":"78","author":"Munroe","year":"2017","journal-title":"J Autoimmun"},{"key":"2025030500184472300_keae134-B35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1042\/bj3090395","article-title":"Identification and characterization of a novel human neutrophil protein related to the S100 family","volume":"309(Pt 2)","author":"Guignard","year":"1995","journal-title":"Biochem J"},{"key":"2025030500184472300_keae134-B36","doi-asserted-by":"crossref","first-page":"25291","DOI":"10.1074\/jbc.274.36.25291","article-title":"S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14","volume":"274","author":"Vogl","year":"1999","journal-title":"J Biol Chem"},{"key":"2025030500184472300_keae134-B37","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1189\/jlb.69.6.986","article-title":"Proinflammatory properties of the human S100 protein S100A12","volume":"69","author":"Yang","year":"2001","journal-title":"J Leukoc Biol"},{"key":"2025030500184472300_keae134-B38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2003.08.021","article-title":"The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophages","volume":"171","author":"Hasegawa","year":"2003","journal-title":"Atherosclerosis"},{"key":"2025030500184472300_keae134-B39","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41392-023-01641-y","article-title":"Single-cell transcriptomic analysis reveals a systemic immune dysregulation in COVID-19-associated pediatric encephalopathy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2025030500184472300_keae134-B40","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1152\/physrev.00046.2011","article-title":"Stem cell factor receptor\/c-Kit: from basic science to clinical implications","volume":"92","author":"Lennartsson","year":"2012","journal-title":"Physiol Rev"},{"key":"2025030500184472300_keae134-B41","doi-asserted-by":"crossref","first-page":"14433","DOI":"10.1038\/s41598-019-50231-y","article-title":"SLE Plasma profiling identifies unique signatures of lupus nephritis and discoid lupus","volume":"9","author":"Smith","year":"2019","journal-title":"Sci Rep"},{"key":"2025030500184472300_keae134-B42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF01451008","article-title":"Significance of stem cell factor and soluble KIT in patients with systemic lupus erythematosus","volume":"17","author":"Kitoh","year":"1998","journal-title":"Clin Rheumatol"},{"key":"2025030500184472300_keae134-B43","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1186\/s12879-022-07761-0","article-title":"Characterization of sepsis inflammatory endotypes using circulatory proteins in patients with severe infection: a prospective cohort study","volume":"22","author":"Rica\u00f1o-Ponce","year":"2022","journal-title":"BMC Infect Dis"},{"key":"2025030500184472300_keae134-B44","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/infdis\/jiab065","article-title":"Dysregulated innate and adaptive immune responses discriminate disease severity in COVID-19","volume":"223","author":"Janssen","year":"2021","journal-title":"J Infect Dis"},{"key":"2025030500184472300_keae134-B45","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1182\/blood.V90.6.2244","article-title":"Interferon gamma downregulates stem cell factor and erythropoietin receptors but not insulin-like growth factor-I receptors in human erythroid colony-forming cells","volume":"90","author":"Taniguchi","year":"1997","journal-title":"Blood"},{"key":"2025030500184472300_keae134-B46","doi-asserted-by":"crossref","first-page":"e7065","DOI":"10.1590\/1414-431x20187065","article-title":"TNF-\u03b1 inhibits SCF, ghrelin, and substance P expressions through the NF-\u03baB pathway activation in interstitial cells of Cajal","volume":"51","author":"Ren","year":"2018","journal-title":"Braz J Med Biol Res"},{"key":"2025030500184472300_keae134-B47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae134\/57122395\/keae134.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/3\/1170\/57122395\/keae134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/3\/1170\/57122395\/keae134.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:21:57Z","timestamp":1741134117000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/3\/1170\/7625065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,9]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,9]]},"published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae134","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,3,9]]}}}